The accumulation of aggrecan, a protein found abundantly in cartilage, may be an early response to injury in the lungs…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
People with pulmonary hypertension (PH) who took dipyrone to help manage pain were at a significantly lower risk of assisted ventilation…
Treatment with C75, an inhibitor of an enzyme called fatty acid synthase (FAS), partially reversed disease processes in a mouse…
Sensydia has completed a development study to assess the effectiveness of its Cardiac Performance System (CPS) in identifying people…
The PHenomenal Impact Fund for Global PH Research is accepting research proposals, according to a press release. On…
Increasing the levels of the Tex261 protein — either as a preventive or therapeutic approach — eased the symptoms…
Infants with pulmonary arterial hypertension (PAH) who were put on Adempas (riociguat) after Revatio (sildenafil) and other…
Children with pulmonary arterial hypertension (PAH) experience lower quality of life because of their functional impairments, especially if they…
Pulmonary hypertension (PH) is linked with changes in the gut microbiome — the vast community of bacteria, fungi, and…
Adempas (riociguat), an approved therapy for adults with pulmonary arterial hypertension (PAH), was well-tolerated in children and adolescents with…
A gene therapy designed to provide a protein implicated in heart function improvement was found to lessen pulmonary blood vessel…
Pulnovo Medical reported that it “successfully concluded” a first meeting with the U.S. Food and Drug Administration (FDA)…